Stock CBD CANNASOUTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Cannasouth Limited

Equities

CBD

NZCBDE0009S6

End-of-day quote New Zealand S.E.
Other stock markets
 07:00:00 2024-03-24 pm EDT 		5-day change 1st Jan Change
0.098 NZD +2.08% Intraday chart for Cannasouth Limited -.--% -26.32%
Apr. 15 Cannasouth Terminates COO MT
Apr. 11 New Zealand Shares Fall on Rate Cut Woes; Cannasouth's CEO Resigns MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
New Zealand Shares Fall on Rate Cut Woes; Cannasouth's CEO Resigns
MT
Cannasouth Limited acquired Eqalis Group New Zealand Limited from Eqalis shareholders.
CI
Cannasouth Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Cannasouth Limited signed a binding term sheet to acquire Eqalis Group New Zealand Limited from Eqalis shareholders for NZD 44.4 million.
CI
Cannasouth Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Cannasouth Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Cannasouth Limited completed the acquisition of remaining 50% stake in Cannasouth Cultivation Limited from Aaron Craig.
CI
Cannasouth Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended 30 June 2021
CI
Cannasouth Limited completed the acquisition of remaining 40% stake in Midwest Pharmaceutics NZ Limited from Greenmeadows Health Limited and Mark Balchin.
CI
Cannasouth Limited signed an agreement to acquire remaining 50% stake in Cannasouth Cultivation Limited from Aaron Craig.
CI
Cannasouth Limited agreed to acquire remaining 40% of stake in Midwest Pharmaceutics NZ Limited from Greenmeadows Health Limited and Mark Balchin for NZD 1 million.
CI
Cannasouth Limited Announces Unaudited Earnings Results for the Year Ended December 31, 2020
CI
Cannasouth Limited Reports Earnings Results for the Half Year Ended June 30, 2020
CI
Cannasouth Limited Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Cannasouth Limited completed the acquisition of 60% stake in Midwest Pharmaceutics NZ Limited.
CI
Cannasouth Limited entered into an agreement to acquire 60% stake in Midwest Pharmaceutics NZ Limited for approximately NZD 1.3 million.
CI
Cannasouth Limited Announces Consolidated Earnings Results for the Six Months Ended 30 June 2019
CI
Cannasouth Limited has completed an IPO in the amount of NZD 10 million.
CI
Cannasouth Limited has filed an IPO in the amount of NZD 10 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CBD Stock
  4. News Cannasouth Limited
  5. Highlights